Question 1

Where is the Siemens Healthineers AG stock traded?

Accepted Answer

The Siemens Healthineers AG stock trades under the ticker SHL.XETRA on the XETRA exchange. ISIN: DE000SHL1006.

Question 2

What does Siemens Healthineers AG do?

Accepted Answer

Siemens Healthineers AG is a company characterized by the following investment thesis:

Question 3

What are the key metrics for SHL.XETRA?

Accepted Answer

Key metrics for SHL.XETRA include valuation (P/E 19.6, P/S 1.9, P/B 2.2), profitability (profit margin 9.55%, ROE 12.15%), and growth (revenue –, earnings –). Market capitalization is 43.28B EUR. These metrics give an overview of the company's financial performance and valuation.

Question 4

How has Siemens Healthineers AG's stock price performed?

Accepted Answer

Siemens Healthineers AG's stock has returned – over 1 year, – over 3 years, and – over 5 years. Performance can vary depending on market conditions and company developments.

Question 5

How is SHL.XETRA valued?

Accepted Answer

SHL.XETRA has the following valuation metrics: P/E Ratio: 19.6, P/S Ratio: 1.9, P/B Ratio: 2.2. These metrics help assess whether the stock is fairly valued compared to its fundamentals.

Question 6

Does SHL.XETRA pay dividends?

Accepted Answer

Yes, SHL.XETRA pays dividends with a dividend yield of 2.6%. Dividends can be an important component of the total return on an investment.

Question 7

What are the key risks when investing in SHL.XETRA?

Accepted Answer

Key risks for SHL.XETRA include: Siemens Healthineers competes across diagnostic imaging, laboratory diagnostics, advanced therapies, and digital and AI-enabled clinical solutions. Its competitors range from large diversified med-tech and diagnostics firms to faster-moving specialty vendors and China-based imaging manufacturers. The company faces material exposure to technology and software disruption through AI and software-defined imaging, pricing and reimbursement pressure across its end markets, regulatory and compliance requirements spanning multiple jurisdictions, and competition from lower-cost entrants and platform players capable of bundling hardware, consumables, and services.Software and AI disruption pose a structural risk: if competitors or new entrants develop superior AI and software platforms that function independently of Siemens' hardware, the company could lose meaningful share in its core markets [1].Pricing and reimbursement pressure could compress margins across hardware, consumables, and services as imaging and diagnostics face downward pricing pressure and lower reimbursement rates.Regulatory and compliance risk stems from product approvals, post-market surveillance, and divergent standards across jurisdictions—EU MDR/IVDR, US FDA, China NMPA—each capable of delaying launches, triggering recalls, or imposing fines.Competition from low-cost and vertically integrated players poses a genuine threat. Chinese vendors and large platform companies are bundling imaging, diagnostics, and services in ways that gain traction in emerging markets and price-sensitive regions, where margin pressure is already intense.Investors should consider these risk factors carefully before making an investment decision.

Question 8

Who are the main competitors of Siemens Healthineers AG?

Accepted Answer

Siemens Healthineers AG competes with several listed peers in its sector. Siemens Healthineers (SHL.XETRA) operates in diagnostic imaging, laboratory diagnostics, point-of-care testing, and image-guided therapy alongside large diversified medical-technology groups and specialist diagnostics firms. Its main public competitors are GE HealthCare, Philips, Roche (Diagnostics), Abbott and Thermo Fisher, with additional competition from medtech firms focused on therapy and oncology such as Medtronic and Elekta, as well as lower-cost and newer entrants including Canon, Fujifilm, and Chinese vendors. The company faces material risks from geopolitical and macroeconomic conditions, regulatory requirements and potential compliance or recall issues tied to complex devices and diagnostics, product-cycle dynamics and technological shifts in areas like AI and molecular diagnostics, and operational vulnerabilities spanning IT infrastructure, cybersecurity, and supply-chain resilience.Koninklijke Philips N.V. (PHIA.AMS)Roche Holding AG (ROG.SWX)Abbott Laboratories (ABT.NYSE)Thermo Fisher Scientific Inc (TMO.NYSE)Medtronic plc (MDT.NYSE)Agfa-Gevaert Group (AGFB.BR)These competitors influence pricing power, growth opportunities and relative valuation.

Question 9

When does Siemens Healthineers AG report earnings?

Accepted Answer

Siemens Healthineers AG's next earnings report date is November 5, 2026.

Period	Siemens Healthineers AG	vs DAX	vs S&P 500 (SPY)
1M	-2.96%	+1.07%	-2.84%
3M	+8.61%	+10.10%	+5.75%
6M	+5.50%	-3.27%	-11.61%
1Y	-15.51%	-21.03%	-31.46%
3Y	-16.07%	-79.84%	-101.44%
5Y	-24.38%	-90.64%	-112.54%

Siemens Healthineers AG Performance

Performance Figures of Siemens Healthineers AG

Relative Performance vs Benchmarks

Get More Stock Analyses Like This

Unlock Premium

Full Analysis

Ready for professional stock analysis?

Try for Free

Learn more